Logo image of SGN

SIGNING DAY SPORTS INC (SGN) Stock Fundamental Analysis

NYSEARCA:SGN - NYSE Arca - US82670R3057 - Common Stock - Currency: USD

1.28  -0.34 (-20.99%)

Premarket: 1.28 0 (0%)

Fundamental Rating

1

Overall SGN gets a fundamental rating of 1 out of 10. We evaluated SGN against 283 industry peers in the Software industry. SGN may be in some trouble as it scores bad on both profitability and health. SGN has a expensive valuation and it also scores bad on growth.


Dividend Valuation Growth Profitability Health

Quickly go to:

0

1. Profitability

1.1 Basic Checks

SGN had negative earnings in the past year.
SGN had a negative operating cash flow in the past year.
SGN Yearly Net Income VS EBIT VS OCF VS FCFSGN Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2020 2021 2022 2023 -2M -4M -6M -8M

1.2 Ratios

Looking at the Return On Assets, with a value of -707.34%, SGN is doing worse than 98.55% of the companies in the same industry.
Industry RankSector Rank
ROA -707.34%
ROE N/A
ROIC N/A
ROA(3y)-592.51%
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
SGN Yearly ROA, ROE, ROICSGN Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2020 2021 2022 2023 0 -500 -1K

1.3 Margins

SGN has a Gross Margin (71.27%) which is comparable to the rest of the industry.
The Profit Margin and Operating Margin are not available for SGN so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 71.27%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
SGN Yearly Profit, Operating, Gross MarginsSGN Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2020 2021 2022 2023 0 -2K -4K -6K -8K

More info and screens

1

2. Health

2.1 Basic Checks

SGN does not have a ROIC to compare to the WACC, probably because it is not profitable.
SGN has less shares outstanding than it did 1 year ago.
SGN has a better debt/assets ratio than last year.
SGN Yearly Shares OutstandingSGN Yearly Shares OutstandingYearly Shares Outstanding 2020 2021 2022 2023 2M 4M 6M 8M
SGN Yearly Total Debt VS Total AssetsSGN Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2020 2021 2022 2023 2M 4M 6M

2.2 Solvency

SGN has an Altman-Z score of -49.49. This is a bad value and indicates that SGN is not financially healthy and even has some risk of bankruptcy.
The Altman-Z score of SGN (-49.49) is worse than 97.09% of its industry peers.
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Altman-Z -49.49
ROIC/WACCN/A
WACC6.12%
SGN Yearly LT Debt VS Equity VS FCFSGN Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2020 2021 2022 2023 0 5M -5M

2.3 Liquidity

A Current Ratio of 0.09 indicates that SGN may have some problems paying its short term obligations.
The Current ratio of SGN (0.09) is worse than 98.18% of its industry peers.
SGN has a Quick Ratio of 0.09. This is a bad value and indicates that SGN is not financially healthy enough and could expect problems in meeting its short term obligations.
Looking at the Quick ratio, with a value of 0.09, SGN is doing worse than 98.18% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 0.09
Quick Ratio 0.09
SGN Yearly Current Assets VS Current LiabilitesSGN Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2020 2021 2022 2023 1M 2M 3M 4M

More info and screens

3

3. Growth

3.1 Past

SGN shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -2546.75%.
Looking at the last year, SGN shows a very strong growth in Revenue. The Revenue has grown by 284.50%.
SGN shows a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 117.25% yearly.
EPS 1Y (TTM)-2546.75%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-3525.58%
Revenue 1Y (TTM)284.5%
Revenue growth 3Y117.25%
Revenue growth 5YN/A
Sales Q2Q%0.36%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
SGN Yearly Revenue VS EstimatesSGN Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2020 2021 2022 2023 100K 200K 300K
SGN Yearly EPS VS EstimatesSGN Yearly EPS VS EstimatesYearly EPS VS Estimates 2020 2021 2022 2023

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for SGN. In the last year negative earnings were reported.
Industry RankSector Rank
PE N/A
Fwd PE N/A
SGN Price Earnings VS Forward Price EarningsSGN Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0 0 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
SGN Per share dataSGN EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 -5 -10 -15

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

SGN does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

SIGNING DAY SPORTS INC

NYSEARCA:SGN (2/28/2025, 8:14:07 PM)

Premarket: 1.28 0 (0%)

1.28

-0.34 (-20.99%)

Chartmill FA Rating
GICS SectorInformation Technology
GICS IndustryGroupSoftware & Services
GICS IndustrySoftware
Earnings (Last)N/A N/A
Earnings (Next)N/A N/A
Inst Owners8.03%
Inst Owner Change-89.23%
Ins Owners5.53%
Ins Owner Change678.85%
Market Cap985.60K
AnalystsN/A
Price TargetN/A
Short Float %36.55%
Short Ratio0.07
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 1.71
P/FCF N/A
P/OCF N/A
P/B N/A
P/tB N/A
EV/EBITDA N/A
EPS(TTM)-16.63
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)-8.9
FCFYN/A
OCF(TTM)-8.88
OCFYN/A
SpS0.75
BVpS-1.98
TBVpS-2.91
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -707.34%
ROE N/A
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 71.27%
FCFM N/A
ROA(3y)-592.51%
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score5
Asset Turnover0.5
Health
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 3.66%
Cap/Sales 2.24%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.09
Quick Ratio 0.09
Altman-Z -49.49
F-Score5
WACC6.12%
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)581.06%
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-2546.75%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-3525.58%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)284.5%
Revenue growth 3Y117.25%
Revenue growth 5YN/A
Sales Q2Q%0.36%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y14.75%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-2.2%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y1.66%
OCF growth 3YN/A
OCF growth 5YN/A